nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolbutamide—CYP2C9—brain cancer	0.887	1	CbGaD
Tolbutamide—SLC15A2—choroid plexus—brain cancer	0.0132	0.2	CbGeAlD
Tolbutamide—SLCO2B1—ganglion—brain cancer	0.00314	0.0478	CbGeAlD
Tolbutamide—KCNJ1—telencephalon—brain cancer	0.00277	0.0421	CbGeAlD
Tolbutamide—Eruption—Hydroxyurea—brain cancer	0.00221	0.0652	CcSEcCtD
Tolbutamide—Gliclazide—VEGFA—brain cancer	0.00207	0.215	CrCbGaD
Tolbutamide—Digestion impaired—Hydroxyurea—brain cancer	0.00203	0.06	CcSEcCtD
Tolbutamide—Glimepiride—CYP2C9—brain cancer	0.00198	0.206	CrCbGaD
Tolbutamide—ABCC8—brainstem—brain cancer	0.00174	0.0265	CbGeAlD
Tolbutamide—KCNJ1—head—brain cancer	0.00173	0.0262	CbGeAlD
Tolbutamide—Glipizide—CYP2C9—brain cancer	0.00172	0.178	CrCbGaD
Tolbutamide—Pancytopenia—Lomustine—brain cancer	0.00165	0.0486	CcSEcCtD
Tolbutamide—Gliclazide—CYP2C9—brain cancer	0.0016	0.166	CrCbGaD
Tolbutamide—Digestion impaired—Temozolomide—brain cancer	0.00159	0.0469	CcSEcCtD
Tolbutamide—KCNJ1—central nervous system—brain cancer	0.00157	0.024	CbGeAlD
Tolbutamide—ABCC8—telencephalon—brain cancer	0.00155	0.0235	CbGeAlD
Tolbutamide—Haemolytic anaemia—Procarbazine—brain cancer	0.00141	0.0417	CcSEcCtD
Tolbutamide—CYP2C18—endocrine gland—brain cancer	0.00132	0.0201	CbGeAlD
Tolbutamide—ABCC8—pituitary gland—brain cancer	0.00126	0.0192	CbGeAlD
Tolbutamide—KCNJ1—brain—brain cancer	0.00125	0.019	CbGeAlD
Tolbutamide—Chlorpropamide—CYP2C9—brain cancer	0.00124	0.129	CrCbGaD
Tolbutamide—ABCC8—medulla oblongata—brain cancer	0.00122	0.0185	CbGeAlD
Tolbutamide—SLCO2B1—telencephalon—brain cancer	0.00121	0.0184	CbGeAlD
Tolbutamide—SLCO1A2—telencephalon—brain cancer	0.00111	0.017	CbGeAlD
Tolbutamide—ABCC8—midbrain—brain cancer	0.00111	0.0169	CbGeAlD
Tolbutamide—ABCC8—spinal cord—brain cancer	0.00108	0.0165	CbGeAlD
Tolbutamide—Leukopenia—Lomustine—brain cancer	0.00108	0.0319	CcSEcCtD
Tolbutamide—KCNJ11—endocrine gland—brain cancer	0.00106	0.0161	CbGeAlD
Tolbutamide—KCNJ11—head—brain cancer	0.00105	0.0159	CbGeAlD
Tolbutamide—Pancytopenia—Procarbazine—brain cancer	0.00105	0.0309	CcSEcCtD
Tolbutamide—Probenecid—CYP2C9—brain cancer	0.00103	0.106	CrCbGaD
Tolbutamide—Photosensitivity reaction—Procarbazine—brain cancer	0.001	0.0297	CcSEcCtD
Tolbutamide—Aplastic anaemia—Temozolomide—brain cancer	0.000996	0.0294	CcSEcCtD
Tolbutamide—ABCC8—endocrine gland—brain cancer	0.000976	0.0149	CbGeAlD
Tolbutamide—Thrombocytopenia—Lomustine—brain cancer	0.000965	0.0285	CcSEcCtD
Tolbutamide—ABCC8—head—brain cancer	0.000964	0.0147	CbGeAlD
Tolbutamide—KCNJ11—central nervous system—brain cancer	0.000955	0.0145	CbGeAlD
Tolbutamide—SLCO2B1—medulla oblongata—brain cancer	0.000952	0.0145	CbGeAlD
Tolbutamide—KCNJ11—cerebellum—brain cancer	0.000934	0.0142	CbGeAlD
Tolbutamide—SLC15A1—endocrine gland—brain cancer	0.000933	0.0142	CbGeAlD
Tolbutamide—SLC15A2—telencephalon—brain cancer	0.000925	0.0141	CbGeAlD
Tolbutamide—ABCC8—central nervous system—brain cancer	0.00088	0.0134	CbGeAlD
Tolbutamide—SLCO1A2—medulla oblongata—brain cancer	0.000876	0.0133	CbGeAlD
Tolbutamide—ABCC8—cerebellum—brain cancer	0.00086	0.0131	CbGeAlD
Tolbutamide—SLCO2B1—spinal cord—brain cancer	0.000849	0.0129	CbGeAlD
Tolbutamide—Pancytopenia—Hydroxyurea—brain cancer	0.000809	0.0239	CcSEcCtD
Tolbutamide—SLC22A6—brain—brain cancer	0.000802	0.0122	CbGeAlD
Tolbutamide—SLCO1A2—midbrain—brain cancer	0.000801	0.0122	CbGeAlD
Tolbutamide—Hyponatraemia—Carmustine—brain cancer	0.0008	0.0236	CcSEcCtD
Tolbutamide—SLCO1A2—spinal cord—brain cancer	0.000781	0.0119	CbGeAlD
Tolbutamide—SLCO2B1—endocrine gland—brain cancer	0.000764	0.0116	CbGeAlD
Tolbutamide—KCNJ11—brain—brain cancer	0.000758	0.0115	CbGeAlD
Tolbutamide—SLCO2B1—head—brain cancer	0.000754	0.0115	CbGeAlD
Tolbutamide—SLC15A2—pituitary gland—brain cancer	0.000753	0.0115	CbGeAlD
Tolbutamide—SLC15A2—medulla oblongata—brain cancer	0.000727	0.0111	CbGeAlD
Tolbutamide—SLCO1A2—endocrine gland—brain cancer	0.000703	0.0107	CbGeAlD
Tolbutamide—ABCC8—brain—brain cancer	0.000698	0.0106	CbGeAlD
Tolbutamide—SLCO1A2—head—brain cancer	0.000694	0.0106	CbGeAlD
Tolbutamide—SLCO2B1—central nervous system—brain cancer	0.000689	0.0105	CbGeAlD
Tolbutamide—Leukopenia—Procarbazine—brain cancer	0.000687	0.0203	CcSEcCtD
Tolbutamide—SLCO2B1—cerebellum—brain cancer	0.000673	0.0102	CbGeAlD
Tolbutamide—Abdominal distension—Temozolomide—brain cancer	0.00067	0.0198	CcSEcCtD
Tolbutamide—SLC15A2—midbrain—brain cancer	0.000664	0.0101	CbGeAlD
Tolbutamide—Pancytopenia—Carmustine—brain cancer	0.000654	0.0193	CcSEcCtD
Tolbutamide—SLC15A2—spinal cord—brain cancer	0.000648	0.00986	CbGeAlD
Tolbutamide—CYP2C8—pituitary gland—brain cancer	0.000634	0.00965	CbGeAlD
Tolbutamide—SLCO1A2—central nervous system—brain cancer	0.000634	0.00964	CbGeAlD
Tolbutamide—Pancytopenia—Temozolomide—brain cancer	0.000632	0.0187	CcSEcCtD
Tolbutamide—SLCO1A2—cerebellum—brain cancer	0.000619	0.00942	CbGeAlD
Tolbutamide—Thrombocytopenia—Procarbazine—brain cancer	0.000613	0.0181	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Temozolomide—brain cancer	0.000607	0.0179	CcSEcCtD
Tolbutamide—Erythema—Hydroxyurea—brain cancer	0.000594	0.0175	CcSEcCtD
Tolbutamide—Nausea—Lomustine—brain cancer	0.000586	0.0173	CcSEcCtD
Tolbutamide—SLC15A2—endocrine gland—brain cancer	0.000584	0.00888	CbGeAlD
Tolbutamide—SLC15A2—head—brain cancer	0.000576	0.00876	CbGeAlD
Tolbutamide—CYP2C19—endocrine gland—brain cancer	0.000563	0.00856	CbGeAlD
Tolbutamide—SLCO2B1—brain—brain cancer	0.000547	0.00832	CbGeAlD
Tolbutamide—Leukopenia—Hydroxyurea—brain cancer	0.000531	0.0157	CcSEcCtD
Tolbutamide—SLC15A2—central nervous system—brain cancer	0.000526	0.008	CbGeAlD
Tolbutamide—SLC15A2—cerebellum—brain cancer	0.000514	0.00782	CbGeAlD
Tolbutamide—Pancytopenia—Etoposide—brain cancer	0.000506	0.0149	CcSEcCtD
Tolbutamide—SLCO1A2—brain—brain cancer	0.000503	0.00765	CbGeAlD
Tolbutamide—Urticaria—Procarbazine—brain cancer	0.000497	0.0147	CcSEcCtD
Tolbutamide—CYP2C8—endocrine gland—brain cancer	0.000491	0.00747	CbGeAlD
Tolbutamide—Erythema—Carmustine—brain cancer	0.00048	0.0142	CcSEcCtD
Tolbutamide—Thrombocytopenia—Hydroxyurea—brain cancer	0.000474	0.014	CcSEcCtD
Tolbutamide—Erythema—Temozolomide—brain cancer	0.000464	0.0137	CcSEcCtD
Tolbutamide—Agranulocytosis—Etoposide—brain cancer	0.000443	0.0131	CcSEcCtD
Tolbutamide—Pruritus—Procarbazine—brain cancer	0.000443	0.0131	CcSEcCtD
Tolbutamide—CYP2C9—endocrine gland—brain cancer	0.000436	0.00664	CbGeAlD
Tolbutamide—Leukopenia—Carmustine—brain cancer	0.00043	0.0127	CcSEcCtD
Tolbutamide—Dyspepsia—Hydroxyurea—brain cancer	0.000426	0.0126	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000418	0.0124	CcSEcCtD
Tolbutamide—SLC15A2—brain—brain cancer	0.000417	0.00635	CbGeAlD
Tolbutamide—Leukopenia—Temozolomide—brain cancer	0.000415	0.0123	CcSEcCtD
Tolbutamide—Rash—Procarbazine—brain cancer	0.000395	0.0117	CcSEcCtD
Tolbutamide—Headache—Procarbazine—brain cancer	0.000392	0.0116	CcSEcCtD
Tolbutamide—Thrombocytopenia—Carmustine—brain cancer	0.000383	0.0113	CcSEcCtD
Tolbutamide—Nausea—Procarbazine—brain cancer	0.000372	0.011	CcSEcCtD
Tolbutamide—Thrombocytopenia—Temozolomide—brain cancer	0.000371	0.0109	CcSEcCtD
Tolbutamide—CYP2C8—brain—brain cancer	0.000351	0.00535	CbGeAlD
Tolbutamide—Gastrointestinal disorder—Carmustine—brain cancer	0.000338	0.00998	CcSEcCtD
Tolbutamide—Dyspepsia—Temozolomide—brain cancer	0.000333	0.00984	CcSEcCtD
Tolbutamide—Leukopenia—Etoposide—brain cancer	0.000332	0.00981	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Temozolomide—brain cancer	0.000327	0.00965	CcSEcCtD
Tolbutamide—Rash—Hydroxyurea—brain cancer	0.000305	0.00902	CcSEcCtD
Tolbutamide—Headache—Hydroxyurea—brain cancer	0.000303	0.00896	CcSEcCtD
Tolbutamide—CYP2C18—Xenobiotics—CYP2C9—brain cancer	0.000302	0.0737	CbGpPWpGaD
Tolbutamide—Urticaria—Temozolomide—brain cancer	0.000301	0.00888	CcSEcCtD
Tolbutamide—Thrombocytopenia—Etoposide—brain cancer	0.000297	0.00876	CcSEcCtD
Tolbutamide—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	0.000291	0.0711	CbGpPWpGaD
Tolbutamide—Nausea—Hydroxyurea—brain cancer	0.000288	0.0085	CcSEcCtD
Tolbutamide—Pruritus—Temozolomide—brain cancer	0.000268	0.00791	CcSEcCtD
Tolbutamide—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.000262	0.0639	CbGpPWpGaD
Tolbutamide—Gastrointestinal disorder—Etoposide—brain cancer	0.000261	0.00772	CcSEcCtD
Tolbutamide—Rash—Carmustine—brain cancer	0.000247	0.00729	CcSEcCtD
Tolbutamide—Headache—Carmustine—brain cancer	0.000245	0.00725	CcSEcCtD
Tolbutamide—Urticaria—Etoposide—brain cancer	0.000241	0.0071	CcSEcCtD
Tolbutamide—Rash—Temozolomide—brain cancer	0.000239	0.00705	CcSEcCtD
Tolbutamide—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000238	0.0581	CbGpPWpGaD
Tolbutamide—Headache—Temozolomide—brain cancer	0.000237	0.007	CcSEcCtD
Tolbutamide—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.000233	0.057	CbGpPWpGaD
Tolbutamide—Nausea—Carmustine—brain cancer	0.000233	0.00687	CcSEcCtD
Tolbutamide—Nausea—Temozolomide—brain cancer	0.000225	0.00664	CcSEcCtD
Tolbutamide—Pruritus—Etoposide—brain cancer	0.000214	0.00633	CcSEcCtD
Tolbutamide—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000212	0.0519	CbGpPWpGaD
Tolbutamide—CYP2C8—CYP2E1 reactions—CYP2C9—brain cancer	0.000203	0.0495	CbGpPWpGaD
Tolbutamide—Rash—Etoposide—brain cancer	0.000191	0.00564	CcSEcCtD
Tolbutamide—Headache—Etoposide—brain cancer	0.00019	0.0056	CcSEcCtD
Tolbutamide—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.000181	0.0442	CbGpPWpGaD
Tolbutamide—Nausea—Etoposide—brain cancer	0.00018	0.00531	CcSEcCtD
Tolbutamide—SLCO2B1—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.00013	0.0318	CbGpPWpGaD
Tolbutamide—CYP2C8—Xenobiotics—CYP2C9—brain cancer	0.000126	0.0307	CbGpPWpGaD
Tolbutamide—CYP2C18—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000125	0.0306	CbGpPWpGaD
Tolbutamide—CYP2C18—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000124	0.0302	CbGpPWpGaD
Tolbutamide—CYP2C8—Tamoxifen metabolism—CYP2C9—brain cancer	0.000121	0.0295	CbGpPWpGaD
Tolbutamide—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.000112	0.0274	CbGpPWpGaD
Tolbutamide—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.000108	0.0263	CbGpPWpGaD
Tolbutamide—CYP2C18—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000102	0.0248	CbGpPWpGaD
Tolbutamide—CYP2C18—FOXA1 transcription factor network—SHH—brain cancer	9.29e-05	0.0227	CbGpPWpGaD
Tolbutamide—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	7.7e-05	0.0188	CbGpPWpGaD
Tolbutamide—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	6.04e-05	0.0147	CbGpPWpGaD
Tolbutamide—CYP2C18—Biological oxidations—CYP2C9—brain cancer	5.4e-05	0.0132	CbGpPWpGaD
Tolbutamide—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	5.39e-05	0.0132	CbGpPWpGaD
Tolbutamide—CYP2C18—Metapathway biotransformation—CYP2C9—brain cancer	5.32e-05	0.013	CbGpPWpGaD
Tolbutamide—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	5.22e-05	0.0127	CbGpPWpGaD
Tolbutamide—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	5.15e-05	0.0126	CbGpPWpGaD
Tolbutamide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	4.66e-05	0.0114	CbGpPWpGaD
Tolbutamide—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	4.6e-05	0.0112	CbGpPWpGaD
Tolbutamide—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	4.23e-05	0.0103	CbGpPWpGaD
Tolbutamide—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	3.78e-05	0.00922	CbGpPWpGaD
Tolbutamide—SLCO2B1—Transmembrane transport of small molecules—S100A10—brain cancer	3.28e-05	0.00802	CbGpPWpGaD
Tolbutamide—ABCC8—Transmembrane transport of small molecules—S100A10—brain cancer	3.05e-05	0.00746	CbGpPWpGaD
Tolbutamide—SLC15A2—Transmembrane transport of small molecules—S100A10—brain cancer	2.75e-05	0.00671	CbGpPWpGaD
Tolbutamide—SLC15A1—Transmembrane transport of small molecules—S100A10—brain cancer	2.55e-05	0.00623	CbGpPWpGaD
Tolbutamide—CYP2C8—Biological oxidations—CYP2C9—brain cancer	2.25e-05	0.00549	CbGpPWpGaD
Tolbutamide—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	2.22e-05	0.00541	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—S100A10—brain cancer	2.02e-05	0.00492	CbGpPWpGaD
Tolbutamide—CYP2C19—Biological oxidations—CYP2C9—brain cancer	2.01e-05	0.0049	CbGpPWpGaD
Tolbutamide—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	1.98e-05	0.00483	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—S100A10—brain cancer	1.89e-05	0.00462	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	1.76e-05	0.00429	CbGpPWpGaD
Tolbutamide—SLCO2B1—Transmembrane transport of small molecules—TRPC6—brain cancer	1.52e-05	0.0037	CbGpPWpGaD
Tolbutamide—ABCC8—Transmembrane transport of small molecules—TRPC6—brain cancer	1.41e-05	0.00344	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.28e-05	0.00314	CbGpPWpGaD
Tolbutamide—SLC15A2—Transmembrane transport of small molecules—TRPC6—brain cancer	1.27e-05	0.0031	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—CYP2C9—brain cancer	1.19e-05	0.00289	CbGpPWpGaD
Tolbutamide—SLC15A1—Transmembrane transport of small molecules—TRPC6—brain cancer	1.18e-05	0.00288	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—CYP2C9—brain cancer	1.15e-05	0.00281	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—BSG—brain cancer	1.01e-05	0.00246	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—BSG—brain cancer	9.77e-06	0.00239	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—TRPC6—brain cancer	9.31e-06	0.00227	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—CYP2C9—brain cancer	9.23e-06	0.00225	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—TRPC6—brain cancer	8.75e-06	0.00214	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—IDH1—brain cancer	8.67e-06	0.00212	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	8.63e-06	0.00211	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—IDH1—brain cancer	8.4e-06	0.00205	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—BSG—brain cancer	7.85e-06	0.00192	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—CYP2C9—brain cancer	7.82e-06	0.00191	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	7.7e-06	0.00188	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—ENO2—brain cancer	6.85e-06	0.00167	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—IDH1—brain cancer	6.75e-06	0.00165	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—BSG—brain cancer	6.65e-06	0.00162	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—ENO2—brain cancer	6.64e-06	0.00162	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	6.31e-06	0.00154	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—IDH1—brain cancer	5.72e-06	0.0014	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	5.63e-06	0.00138	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—ENO2—brain cancer	5.34e-06	0.0013	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	5.14e-06	0.00125	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	4.66e-06	0.00114	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—ENO2—brain cancer	4.52e-06	0.0011	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CYP2C9—brain cancer	3.84e-06	0.000938	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CYP2C9—brain cancer	3.43e-06	0.000838	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—BSG—brain cancer	3.27e-06	0.000798	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—PIK3CG—brain cancer	3.14e-06	0.000767	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—PIK3CG—brain cancer	3.05e-06	0.000744	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—BSG—brain cancer	2.92e-06	0.000712	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—IDH1—brain cancer	2.81e-06	0.000686	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—BSG—brain cancer	2.66e-06	0.000649	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—IDH1—brain cancer	2.51e-06	0.000612	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—PIK3CG—brain cancer	2.45e-06	0.000598	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.29e-06	0.000559	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—IDH1—brain cancer	2.29e-06	0.000558	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ENO2—brain cancer	2.22e-06	0.000542	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PIK3CG—brain cancer	2.07e-06	0.000506	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.04e-06	0.000499	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ENO2—brain cancer	1.98e-06	0.000484	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.86e-06	0.000455	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ENO2—brain cancer	1.81e-06	0.000441	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PIK3CG—brain cancer	1.02e-06	0.000249	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PIK3CG—brain cancer	9.09e-07	0.000222	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PIK3CG—brain cancer	8.29e-07	0.000202	CbGpPWpGaD
